Literature DB >> 22142852

Early developmental expression of connexin26 in the cochlea contributes to its dominate functional role in the cochlear gap junctions.

Yan Qu1, Wenxue Tang, Binfei Zhou, Shoeb Ahmad, Qing Chang, Xiaoming Li, Xi Lin.   

Abstract

Mutations in Gjb2 and Gjb6 genes, coding for connexin26 (Cx26) and Cx30 proteins, respectively, are linked to about half of all cases of human autosomal non-syndromic prelingual deafness. Molecular mechanisms of the hearing impairments, however, are unclear. Most cochlear gap junctions (GJs) are co-assembled from Cx26 and Cx30 and deletion of either one of them causes deafness. Our previous studies have shown that normal hearing is possible in the absence of the Cx30 gene when Cx26 is over-expressed. To further test unique functional requirements for various types of connexins in the hearing, we investigated whether the hearing in the conditional Cx26 (cCx26) null mice could be rescued by genetically over-expressing Cx30. Multiple lines of control and experimental mouse models were used. Auditory brainstem response (ABR) measurements showed normal hearing in targeted gene deletion mice when the deleted Cx26 or Cx30 was transgenically expressed from integrated bacterial artificial chromosome (BAC), demonstrating the effectiveness of the BAC rescue approach. In contrast, severe hearing loss was found in cCx26 null mice in which Cx30 was over-expressed. Morphology observations were consistent with the ABR data. Cochleae of cCx26 null mice with and without the transgenic over-expression of Cx30 both showed the typical immature feature of postnatal cochlear development-the closed tunnel of Corti. Immunolabeling data and Western blot quantification indicated that the Cx26 protein expression preceded that of Cx30 during the early postnatal period in the cochlea. Null expression of Cx26 may therefore uniquely result in a transient period when a total elimination of GJs in functionally-important regions of the developing cochlea is possible. We conclude that Cx26 plays an essential role in the development of the auditory sensory epithelium and its unique developmental functions required for normal hearing is not replaceable by Cx30.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22142852      PMCID: PMC3259187          DOI: 10.1016/j.bbrc.2011.11.093

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  K+ cycling and the endocochlear potential.

Authors:  Philine Wangemann
Journal:  Hear Res       Date:  2002-03       Impact factor: 3.208

Review 2.  Transfer of biologically important molecules between cells through gap junction channels.

Authors:  David B Alexander; Gary S Goldberg
Journal:  Curr Med Chem       Date:  2003-10       Impact factor: 4.530

3.  A deletion involving the connexin 30 gene in nonsyndromic hearing impairment.

Authors:  Ignacio del Castillo; Manuela Villamar; Miguel A Moreno-Pelayo; Francisco J del Castillo; Araceli Alvarez; Dolores Tellería; Ibis Menéndez; Felipe Moreno
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

4.  The prevalence of connexin 26 ( GJB2) mutations in the Chinese population.

Authors:  Xue Zhong Liu; Xia Juan Xia; Xiao Mei Ke; Xiao Mei Ouyang; Li Lin Du; Yu He Liu; Simon Angeli; Fred F Telischi; Walter E Nance; Thomas Balkany; Li Rong Xu
Journal:  Hum Genet       Date:  2002-08-16       Impact factor: 4.132

5.  Gap junctions in the inner ear: comparison of distribution patterns in different vertebrates and assessement of connexin composition in mammals.

Authors:  Andrew Forge; David Becker; Stefano Casalotti; Jill Edwards; Nerissa Marziano; Graham Nevill
Journal:  J Comp Neurol       Date:  2003-12-08       Impact factor: 3.215

6.  Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death.

Authors:  Martine Cohen-Salmon; Thomas Ott; Vincent Michel; Jean Pierre Hardelin; Isabelle Perfettini; Michel Eybalin; Tao Wu; Daniel C Marcus; Philine Wangemann; Klaus Willecke; Christine Petit
Journal:  Curr Biol       Date:  2002-07-09       Impact factor: 10.834

7.  Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice.

Authors:  Shoab Ahmad; Shanping Chen; Jianjun Sun; Xi Lin
Journal:  Biochem Biophys Res Commun       Date:  2003-07-25       Impact factor: 3.575

8.  Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential.

Authors:  Barbara Teubner; Vincent Michel; Jörg Pesch; Jürgen Lautermann; Martine Cohen-Salmon; Goran Söhl; Klaus Jahnke; Elke Winterhager; Claus Herberhold; Jean-Pierre Hardelin; Christine Petit; Klaus Willecke
Journal:  Hum Mol Genet       Date:  2003-01-01       Impact factor: 6.150

9.  Connexin30 null and conditional connexin26 null mice display distinct pattern and time course of cellular degeneration in the cochlea.

Authors:  Yu Sun; Wenxue Tang; Qing Chang; Yunfeng Wang; Weijia Kong; Xi Lin
Journal:  J Comp Neurol       Date:  2009-10-20       Impact factor: 3.215

10.  A non-syndrome form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q.

Authors:  P Guilford; S Ben Arab; S Blanchard; J Levilliers; J Weissenbach; A Belkahia; C Petit
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

View more
  16 in total

1.  Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss.

Authors:  Eric R Press; Qing Shao; John J Kelly; Katrina Chin; Anton Alaga; Dale W Laird
Journal:  J Biol Chem       Date:  2017-04-20       Impact factor: 5.157

Review 2.  Genetics of hearing and deafness.

Authors:  Simon Angeli; Xi Lin; Xue Zhong Liu
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

3.  Assembly of the cochlear gap junction macromolecular complex requires connexin 26.

Authors:  Kazusaku Kamiya; Sabrina W Yum; Nagomi Kurebayashi; Miho Muraki; Kana Ogawa; Keiko Karasawa; Asuka Miwa; Xueshui Guo; Satoru Gotoh; Yoshinobu Sugitani; Hitomi Yamanaka; Shioko Ito-Kawashima; Takashi Iizuka; Takashi Sakurai; Tetsuo Noda; Osamu Minowa; Katsuhisa Ikeda
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 4.  The role of connexins in ear and skin physiology - functional insights from disease-associated mutations.

Authors:  Ji Xu; Bruce J Nicholson
Journal:  Biochim Biophys Acta       Date:  2012-07-13

Review 5.  Cellular and Deafness Mechanisms Underlying Connexin Mutation-Induced Hearing Loss - A Common Hereditary Deafness.

Authors:  Jeffrey C Wingard; Hong-Bo Zhao
Journal:  Front Cell Neurosci       Date:  2015-05-29       Impact factor: 5.505

6.  Preferentially regulated expression of connexin 43 in the developing spiral ganglion neurons and afferent terminals in post-natal rat cochlea.

Authors:  W J Liu; J Yang
Journal:  Eur J Histochem       Date:  2015-02-11       Impact factor: 3.188

Review 7.  Aberrant Cx26 hemichannels and keratitis-ichthyosis-deafness syndrome: insights into syndromic hearing loss.

Authors:  Helmuth A Sanchez; Vytas K Verselis
Journal:  Front Cell Neurosci       Date:  2014-10-27       Impact factor: 5.505

8.  Mouse Panx1 Is Dispensable for Hearing Acquisition and Auditory Function.

Authors:  Veronica Zorzi; Fabiola Paciello; Gaia Ziraldo; Chiara Peres; Flavia Mazzarda; Chiara Nardin; Miriam Pasquini; Francesco Chiani; Marcello Raspa; Ferdinando Scavizzi; Andrea Carrer; Giulia Crispino; Catalin D Ciubotaru; Hannah Monyer; Anna R Fetoni; Anna M Salvatore; Fabio Mammano
Journal:  Front Mol Neurosci       Date:  2017-11-28       Impact factor: 5.639

9.  Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice.

Authors:  Q Yu; Y Wang; Q Chang; J Wang; S Gong; H Li; X Lin
Journal:  Gene Ther       Date:  2013-11-14       Impact factor: 5.250

Review 10.  Practical aspects of inner ear gene delivery for research and clinical applications.

Authors:  Sungsu Lee; Anna Dondzillo; Samuel P Gubbels; Yehoash Raphael
Journal:  Hear Res       Date:  2020-03-06       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.